Pharma Industry Report: Top 10 Drugs

September 19, 2016


What is the current state of the global pharmaceutical market, including key drivers, and how will the industry evolve in the coming decade?

Find out in this exclusive report produced by Scrip Intelligence, Informa Pharma Intelligence and Datamonitor in collaboration with EBD Group.

Topics covered in this report include:

  • Top 10 pharma companies 2016
  • Top 10 pharma R&D spenders 2016
  • Top 10 companies by pipeline size
  • Top oncology-focused partnerships signed 2016, and more.

This report identifies the top performing companies and products across a number of key metrics. You will not only find out which drugs are the best selling, but also those which are fast growing and will likely be top of the pile in the coming years. Moreover, you will find out which employees deliver the most value to their shareholders and who are the best paid CEOs.

Download the report now.

Share your email address with EBD Group to open the whitepaper. Unsubscribe to our news at any time. Learn More: EBD Group Terms of Use Privacy Policy

Discover partnering opportunities at BIO-Europe Spring, the premier springtime partnering conference bringing together a “whoʼs who” from biotech, pharma and finance in Europe’s most innovative biopharma clusters. 


Previous Article
Digital medicine: Invest in innovation
Digital medicine: Invest in innovation

It’s too soon to say, definitively, whether digital medicine will be disruptive or adjunctive for drug deve...

Next Article
How Do Healthcare Investors and Payers Separate the Tools From the Toys?
How Do Healthcare Investors and Payers Separate the Tools From the Toys?

  Guest post by Nicole Fisher, Founder & CEO at HHR Strategies, Inc., Forbes Contributor The healthcare sec...